Drug shortage
Dacarbazine Injection · Fresenius Kabi USA, LLC
FDA drug shortage · Resolved · updated Jan 13, 2025
Key facts
| Generic name | Dacarbazine Injection |
|---|---|
| Company | Fresenius Kabi USA, LLC |
| Presentation | Injection, 10 mg/1 mL (NDC 63323-127-10) |
| Dosage form | Injection |
| Strength | 10 mg/1 mL |
| Status | Resolved |
| Therapeutic category | Oncology |
| Package NDCs | 63323-127-10 |
| First posted | Oct 20, 2021 |
| Last updated | Jan 13, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: